Scientists reveal how cancer cells use a sugar shield to evade immunity—and how a new therapy helps the immune system fight back.
Category: What’s new
Fda Real-world Evidence Update ExplainedFda Real-world Evidence Update Explained
Most medicines and medical devices, as you may already know, go through a long journey of carefully controlled clinical trials before reaching the market. These trials are absolutely essential. However,
FDA’s TEMPO Pilot: A Boon for Chronic Disease CareFDA’s TEMPO Pilot: A Boon for Chronic Disease Care
FDA just launched TEMPO, a digital health strategy that can come as a boon for people with chronic ailments.
Why India Is the Diabetes Capital: New ICMR Data Exposes the Real CulpritWhy India Is the Diabetes Capital: New ICMR Data Exposes the Real Culprit
India has long held the title of Diabetes capital. It was high time to look into it so ICMR surveyed around 18000 people. The result-shocking!
Durvalumab Approved by FDA: Here’s What You Should KnowDurvalumab Approved by FDA: Here’s What You Should Know
Durvalumab, a monoclonal antibody gets a nod from the FDA to be used in resectable stomach cancers. Read more for full story.